Patient-Reported Symptom Monitoring Aids Cancer Treatment Outcomes
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 14, 2025 -- Electronic symptom monitoring with patient-reported outcomes (PRO) meaningfully improves clinical outcomes for cancer treatment, according to a study published online Feb. 7 in Nature Medicine.
Ethan Basch, M.D., from the University of North Carolina at Chapel Hill, and colleagues assessed whether symptom monitoring with electronic PRO improves clinical outcomes during cancer treatment. The analysis included 1,191 enrolled patients seen at 52 oncology practices who were randomly assigned to PRO or usual care.
The researchers found no difference in survival. However, with PRO, time to first emergency visit was significantly prolonged versus usual care, with a 6.1 percent reduction in the cumulative incidence of emergency visits and fewer mean visits at 12 months with PRO (1.02 versus 1.30). PRO was also significantly favored for delayed deterioration of physical function (median, 12.6 versus 8.5 months), symptoms (12.7 versus 9.9) and health-related quality of life (15.6 versus 12.2), which remained significant when considering deaths in analyses. More than three-quarters of patients (77 percent) felt that PRO improved discussions with the care team, while 84.0 percent said it made them feel more in control of their care (84.0 percent) and 91.4 percent would recommend it to other patients. The vast majority completed weekly symptom surveys (91.5 percent).
"These findings demonstrate that symptom monitoring with PRO meaningfully improves clinical outcomes, the patient experience, and utilization of services and should be included as a standard part of quality cancer clinical care," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Biomarker Panel Improves Prediction of CKD Progression in Children
TUESDAY, June 24, 2025 -- A biomarker panel can improve prediction of chronic kidney disease (CKD) progression in children, according to a study published in the June issue of the...
Relative Peripheral Refraction Predicts Myopia Progression in Children
TUESDAY, June 24, 2025 -- Vertical and horizontal relative peripheral refraction (RPR) are associated with faster axial length progression and higher risk of incident myopia...
Hydrops MRI Accurately Differentiates Meniere Disease, Vestibular Migraine
MONDAY, June 23, 2025 -- The combination of cochlear endolymphatic hydrops (CEH) and vestibular endolymphatic hydrops (VEH) on magnetic resonance imaging (MRI) accurately...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.